Venue: Crowne Plaza Woburn, Woburn, MA
Format: Oral presentation: Crossing the Divide: Leveraging Fibrosis-Inflammatory Biomarkers to Inform Clinical Trial Design
Session: Illuminating the Latest in Fibrotic Biomarkers Across Indications to Harness Predictive and Progressive Biomarkers in Clinical Development
Time: November 10, 2022, 11:00 am ET
Presenter: Adi Mor, PhD, Co-Founder & Chief Scientific Officer, Chemomab
A copy of the presentation will be available at the R&D section of Chemomab’s website (www.chemomab.com).